Edition:
India

C R Bard Inc (BCR.N)

BCR.N on New York Stock Exchange

335.18USD
22 Nov 2017
Change (% chg)

$-1.48 (-0.44%)
Prev Close
$336.66
Open
$335.95
Day's High
$335.95
Day's Low
$334.50
Volume
318,062
Avg. Vol
136,961
52-wk High
$336.98
52-wk Low
$206.28

Select another date:

Thu, Oct 26 2017

BRIEF-BD announces extension of exchange offers and consent solicitations for C. R. Bard, Inc.

* BD announces extension of exchange offers and consent solicitations for C. R. Bard, Inc. Notes Source text for Eikon: Further company coverage:

BRIEF-C R Bard reports Q3 earnings per share $1.25

* Q3 earnings per share view $2.95 -- Thomson Reuters I/B/E/S

Becton Dickinson wins conditional EU approval for $24 billion Bard buy

BRUSSELS U.S. medical equipment supplier Becton Dickinson secured EU antitrust approval for its $24-billion acquisition of U.S. peer C R Bard after it agreed to sell two businesses to allay competition concerns.

Becton Dickinson wins conditional EU approval for $24 bln Bard buy

BRUSSELS, Oct 18 U.S. medical equipment supplier Becton Dickinson secured EU antitrust approval for its $24-billion acquisition of U.S. peer C R Bard after it agreed to sell two businesses to allay competition concerns.

BRIEF-BD extends exchange offers and consent solicitations for C R Bard Inc notes

* BD announces extension of exchange offers and consent solicitations for C R Bard Inc notes

BRIEF-BD announces extension of exchange offers and consent solicitations for C. R. Bard Inc notes

* BD announces extension of exchange offers and consent solicitations for C. R. Bard Inc notes

BRIEF-C. R. Bard receives FDA premarket approval of the Lutonix

* C. R. Bard receives fda premarket approval of the lutonix® 035 drug coated balloon as the first and only DCB for the treatment of patients with dysfunctional av fistulae

BRIEF-C.R. Bard shareholders approve proposed merger with Becton Dickinson

* Bard shareholders approve proposed merger with becton, dickinson

BRIEF-Becton Dickinson extends exchange for C. R. Bard, Inc. notes

* BD announces extension of exchange offers and consent solicitations for C. R. Bard, Inc. Notes

BRIEF-C R Bard receives civil investigative demand by DOJ in July

* Says in July, separate civil investigative demand was served to company by DOJ

Select another date: